Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its pharmacokinetic variability and a narrow therapeutic index, the safe administration of the drug requires its therapeutic drug monitoring (...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2022-04-01
|
| Serija: | Biomolecules |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2218-273X/12/4/590 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
